Phase I, Open Label, Single Center Safety Study of [F-18]FLT
NCT00553748
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
11
Enrollment
INDUSTRY
Sponsor class
Conditions
Brain Cancer
Interventions
DRUG:
F-18 FLT
Sponsor
Siemens Molecular Imaging